Overview
John Shields is a Hematologist Oncology specialist and a Hematologist practicing medicine in Reno, Nevada.
Dr. Shields is highly rated in 5 conditions, according to our data. His clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Familial Pancreatic Cancer, and Pancreatic Cancer.
Specialties
Licenses
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Locations
Cancer Care Specialists
Sowjanya Reganti is a Hematologist and an Oncologist practicing medicine in Reno, Nevada. Dr. Reganti is highly rated in 41 conditions, according to our data. Her clinical expertise encompasses Paget Disease of the Breast, Breast Cancer, Familial Colorectal Cancer, and Familial Pancreatic Cancer. Dr. Reganti is board certified in American Board Of Internal Medicine. Dr. Reganti is currently accepting new patients.
Cancer Care Specialists
Suresh Reddy is a Hematologist and an Oncologist practicing medicine in Reno, Nevada. Dr. Reddy is highly rated in 59 conditions, according to our data. His clinical expertise encompasses Paget Disease of the Breast, Angiosarcoma, Inflammatory Breast Cancer, Neuroendocrine Tumor, and Bone Marrow Aspiration. Dr. Reddy is board certified in American Board Of Internal Medicine. Dr. Reddy is currently accepting new patients.
Cancer Care Specialists
Santhosh Ambika is a Hematologist and an Oncologist practicing medicine in Reno, Nevada. Dr. Ambika is highly rated in 70 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Pleuropulmonary Blastoma, Follicular Lymphoma, Hodgkin Lymphoma, and Bone Marrow Aspiration. Dr. Ambika is board certified in American Board Of Internal Medicine. Dr. Ambika is currently accepting new patients.
Frequently Asked Questions about Dr. John A. Shields
How do I make an appointment with Dr. John A. Shields?
You can book an appointment with Dr. John A. Shields by calling their office at 775-329-0873. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. John A. Shields a top-rated expert for Breast Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. John A. Shields is classified as an Advanced expert for Breast Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. John A. Shields specialize in?
While Dr. John A. Shields is a Hematology Oncology, they have specific expertise in Breast Cancer, Paget Disease of the Breast, and Familial Pancreatic Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology Oncology.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Breast CancerDr. Shields isAdvanced. Learn about Breast Cancer.
- ChoriocarcinomaDr. Shields isAdvanced. Learn about Choriocarcinoma.
- Familial Pancreatic CancerDr. Shields isAdvanced. Learn about Familial Pancreatic Cancer.
- Paget Disease of the BreastDr. Shields isAdvanced. Learn about Paget Disease of the Breast.
- Pancreatic CancerDr. Shields isAdvanced. Learn about Pancreatic Cancer.
- Experienced
- Acute Eosinophilic PneumoniaDr. Shields isExperienced. Learn about Acute Eosinophilic Pneumonia.
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Shields isExperienced. Learn about Acute Myeloid Leukemia (AML).
- ALK-Positive Non-Small Cell Lung CancerDr. Shields isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- AngiosarcomaDr. Shields isExperienced. Learn about Angiosarcoma.